Geron Corp (NASDAQ:GERN)

1.33
Delayed Data
As of May 13
 -0.04 / -2.90%
Today’s Change
1.22
Today|||52-Week Range
2.40
-16.35%
Year-to-Date
Geron (GERN) Q1 2021 Earnings Call Transcript
May 11 / MotleyFool.com - Paid Partner Content
Geron (GERN) Reports Q1 Loss, Tops Revenue Estimates
May 10 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close1.38
Today’s open1.39
Day’s range1.30 - 1.40
Volume2,219,791
Average volume (3 months)3,295,426
Market cap$425.2M
Data as of 3:59pm ET, 05/13/2021

Growth & Valuation

Earnings growth (last year)+22.72%
Earnings growth (this year)-18.95%
Earnings growth (next 5 years)+2.00%
Revenue growth (last year)-45.00%
P/E ratioNM
Price/Sales1,706.02
Price/Book1.97

Competitors

 Today’s
change
Today’s
% change
CUECue Biopharma Inc-1.09-7.76%
----
FBRXForte Biosciences In...-2.43-7.16%
APLTApplied Therapeutics...-1.69-10.65%
Data as of 4:46pm ET, 05/13/2021

Financials

Next reporting dateAugust 4, 2021
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$253.0K
Annual profit (last year)-$75.6M
Net profit margin-29,888.14%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Foster City, California

Forecasts